Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Non-Current Debt (2016 - 2022)

Historic Non-Current Debt for Alaunos Therapeutics (TCRT) over the last 3 years, with Q2 2022 value amounting to $4.5 million.

  • Alaunos Therapeutics' Non-Current Debt changed N/A to $4.5 million in Q2 2022 from the same period last year, while for Jun 2022 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $16.2 million for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q2 2022, Alaunos Therapeutics' Non-Current Debt is $4.5 million.
  • Alaunos Therapeutics' Non-Current Debt's 5-year high stood at $16.2 million during Q4 2021, with a 5-year trough of $4.5 million in Q2 2022.